📰 Ted Human Effector Cell Relocation Phase News
Ted Human Effector Cell Relocation Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ted Human Effector Cell Relocation Phase. Real-time updates on events, politics, business and more.
May 23, 2024
Oral presentation in "Developmental Therapeutics-Immunotherapy" session on Sunday, June 2, 2024, at 11:30 AM CDT CatalYm today announced that positive new follow-up results from its ongoing "GDFATHER"
June 5, 2023
Oral presentation highlights first data from the GDFATHER-2a trial demonstrating lasting and confirmed responses (as per RECIST criteria) following treatment with visugromab and the anti-PD-1 inhibitor
May 25, 2023
Oral presentation in "Developmental Therapeutics-Immunotherapy" session on Sunday, June 4 at 9:45 AM CDT CatalYm today announced that the first results from its ongoing Phase 2a trial "GDFATHER-2"